发明名称 |
Sustained release pharmaceutical composition containing glipizide and method for producing same |
摘要 |
One aspect of the invention resides in a monolithic sustained release composition of glipizide for patients with non-insulin dependent diabetes mellitus that exhibits a breakdown after ingestion by a patient in conformity with a zero-order kinetic. The present invention provides a composition of a glipizide and a hydrocolloid forming agent and optimally other auxiliary excipients for the sustained release of glipizide. It is preferable that the hydrophilic material comprises at least 50% by weight of the composition. The present invention is also directed to the process for producing the composition. One aspect of this process includes the steps of granulating glipizide, a hydrophilic material and a diluent, drying the granulated product and lubricating the product with a flow regulating agent and lubricant.
|
申请公布号 |
US6270797(B1) |
申请公布日期 |
2001.08.07 |
申请号 |
US20000573290 |
申请日期 |
2000.05.18 |
申请人 |
USV LIMITED |
发明人 |
GIDWANI SURESH KUMAR;SINGNURKAR PURUSHOTTAM;TEWARI PRASHANT KUMAR |
分类号 |
A61K9/20;A61K9/22;A61K9/26;A61K9/52;A61K31/4965;(IPC1-7):A61K9/52 |
主分类号 |
A61K9/20 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|